Oxaliplatin: third-generation platinum analog.
نویسنده
چکیده
Gail Wilkes, RNC, MS, AOCN®, is an oncology nurse educator at Boston Medical Center in Massachusetts. Wilkes is a member of the speaker’s bureau for Sanofi-Synthelabo, Inc., the manufacturer of oxaliplatin (EloxatinTM). (Mention of specific products and opinions related to those products do not indicate or imply endorsement by the Clinical Journal of Oncology Nursing or the Oncology Nursing Society.)
منابع مشابه
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance
Oxaliplatin is a third-generation platinum compound that has shown a wide range of anti-tumour activity in metastatic cancer and in multiple cell lines. It contains a diaminocyclohexane carrier ligand and is one of the least toxic platinum agents. In the past decade, the use of oxaliplatin for the treatment of colorectal cancer has become increasingly popular because neither cisplatin nor carbo...
متن کاملClinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.
Oxaliplatin, a third generation novel platinum compound is the most effective first line chemotherapeutic agent for colorectal cancer (CRC) in combination with 5FU and leucovorin. It is indicated for pancreatic, gastric and testicular cancers combined with bevacuzimab, capecitabine, irinotecan and other cytotoxic agents. However, moderate to severe hypersensitivity reactions (HSR) during or aft...
متن کاملOxaliplatin with 5-FU or as a single agent in advanced/metastatic colorectal cancer.
No adequate second- or third-line therapy is available in the United States for patients with metastatic colorectal cancer and disease progression following treatment with fluorouracil (5-FU)-based therapy and an irinotecan (CPT-11, Camptosar)-containing regimen, or a combination of the two. Oxaliplatin (Eloxatin), a new platinum analog, has demonstrated high activity in the treatment of colore...
متن کاملOtotoxicity associated with oxaliplatin in a patient with pancreatic cancer.
CONTEXT Oxaliplatin, a third-generation platinum derivative is commonly used for the treatment of colorectal cancer, pancreatic cancer, upper gastrointestinal cancer, hepatobiliary cancer, and ovarian cancer. Neurotoxicity is the dose limiting toxicity and ototoxicity is very rare, less than 1% of patients. CASE REPORT We present a case of a female patient with locally advanced unresectable p...
متن کاملCrystal Structure of an Oxaliplatin 1,2-d(GpG) Intrastrand Cross-link in a DNA Dodecamer Duplex
(1R,2R-Diaminocyclohexane)oxalatoplatinum(II) (oxaliplatin) is a third generation platinum anticancer compound that produces the same type of interand intrastrand DNA cross-links as cisplatin. In combination with 5-fluorouracil, oxaliplatin has been recently approved in Europe, Asia, and Latin America for the treatment of metastatic colorectal cancer. We present here the crystal structure of an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical journal of oncology nursing
دوره 7 3 شماره
صفحات -
تاریخ انتشار 2003